TIDMRTW

RNS Number : 2239A

RTW Venture Fund Limited

17 January 2020

LEI: 549300Q7EXQQH6KF7Z84

17 January 2020

RTW Venture Fund Limited

(the "Company")

ISSUE OF EQUITY

Further to the announcement released 16 January 2020 regarding the issue of equity, the Company confirms that application for admission has been made to London Stock Exchange plc and it is expected that admission will occur at 8:00 a.m. on 22 January 2020.

For further information, please contact:

 
 RTW Investments, LP 
  Stephanie Sirota, Chief Business Officer 
  Alexandra Taracanova, PhD, Director of Investor 
  Relations 
  Julia Enright, Business Development Associate      +1 (646) 343 9280 
 J.P. Morgan Cazenove 
  William Simmonds 
  Ed Murray 
  Oliver Kenyon 
  James Bouverat (Sales)                                +44 (0)20 7742 
  Eddie Nissen (Sales)                                            4000 
 Estera International Fund Managers (Guernsey) 
  Limited                                             +44 (0) 1481 742 
  Kevin Smith                                                      642

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

IOEQDLFFBFLFBBQ

(END) Dow Jones Newswires

January 17, 2020 11:30 ET (16:30 GMT)

Grafico Azioni Rtw Biotech Opportunities (LSE:RTW)
Storico
Da Mar 2024 a Apr 2024 Clicca qui per i Grafici di Rtw Biotech Opportunities
Grafico Azioni Rtw Biotech Opportunities (LSE:RTW)
Storico
Da Apr 2023 a Apr 2024 Clicca qui per i Grafici di Rtw Biotech Opportunities